Abstract:Multidrug efflux pumps export drugs by primary or secondary active transport and pose great challenges in antibiotic resistance and cancer biology. Understanding molecular transport is necessary to inhibit or even reverse the action of these proteins and target drug resistance. One class of bacterial efflux pumps, the Small Multidrug Resistance transporters (SMRs), remove toxic compounds from many multidrug-resistant pathogens, including S. aureus, P. aeruginosa, and M. tuberculosis, via proton-coupled transport. SMRs were thought to confer only resistance to drugs and antiseptics via tightly-coupled antiport, but recent evidence demonstrates that EmrE, an SMR from E. coli and a model for understanding transport, can perform antiport, symport, and/or uniport based on a “free-exchange” model. This model suggests that SMRs may induce susceptibility to some compounds rather than resistance, either through direct influx/symport or by rundown of the proton-motive force (PMF) through uncontrolled proton uniport. PMF rundown is a relatively unexplored drug target, and is orthogonal to the targets of most known antibiotics. Additionally, this is a powerful strategy as it requires an SMR to be merely present, rather than be the primary resistance mechanism, and also eliminates the energy source for many other efflux pumps. This study investigates PaSMR, an EmrE homolog from P. aeruginosa, hypothesizing that PaSMR confers susceptibility, rather than resistance, to some compounds. Novel substrates of PaSMR were discovered by phenotypic microarray and validated by growth curves, comparing E. coli expressing WT PaSMR and a transport-dead mutant to determine if PaSMR confers resistance or susceptibility to these substrates. PaSMR conferred susceptibility to harmane, a small molecule, supporting application of the free-exchange model to SMRs besides EmrE. PaSMR also confers resistance to previously untested antibiotics and natural products. Electrophysiology experiments demonstrate that phenotype aligns with transport mode; that is, antiport results in a resistance phenotype and symport or uniport in susceptibility. PaSMR confers susceptibility to harmane by triggering proton uniport, dissipating the PMF even in the presence of more powerful multidrug efflux pumps. Finally, 2D NMR chemical assignments for PaSMR allow comparison of binding interactions of different substrates, leading towards the molecular determinants of transport behavior and opposite phenotypes. The conclusion is that PaSMR does display more complex transport behavior consistent with the free-exchange model. This leads towards inducing susceptibility and using PMF rundown as a possible therapeutic target for multidrug-resistant infections, as well as broader shifts in our understanding of transporters as capable of diverse transport behaviors. NIH R01GM095839, R35GM141748 (KAHW); 1F31AI169825-01, T32GM135066 (AKW). This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

The Pseudomonas aeruginosa efflux pump MexGHI-OpmD transports a natural phenazine that controls gene expression and biofilm development

Quorum-sensing Regulation of Phenazine Production Heightens Pseudomonas Aeruginosa Resistance to Ciprofloxacin.

Two Regulators, PA3898 and PA2100, Modulate the Pseudomonas aeruginosa Multidrug Resistance MexAB-OprM and EmrAB Efflux Pumps and Biofilm Formation

Antibiotic influx and efflux in Pseudomonas aeruginosa: Regulation and therapeutic implications

Inhibition of Pseudomonas aeruginosa quorum sensing by chemical induction of the MexEF-oprN efflux pump

Expression of Multi-Drug Efflux Pump Gene in Pseudomonas Aeruginosa Biofilms.

Antibiotic-Induced Changes in Efflux Transporter Expression: A Key Factor in Pseudomonas aeruginosa Biofilm Resistance

Phenazine Production Promotes Antibiotic Tolerance and Metabolic Heterogeneity in Pseudomonas Aeruginosa Biofilms.

Changes in the expression of mexB , mexY , and oprD in clinical Pseudomonas aeruginosa isolates

The Pseudomonas Aeruginosa Multidrug Efflux Regulator MexR Uses an Oxidation-Sensing Mechanism

Uncovering the Resistance Mechanisms in Extended-Drug-Resistant Pseudomonas aeruginosa Clinical Isolates: Insights from Gene Expression and Phenotypic Tests

Identification of Efflux Substrates Using a Riboswitch-Based Reporter in Pseudomonas aeruginosa

Inducing susceptibility with a Small Multidrug Resistance transporter from P. aeruginosa

Cpxr Activates Mexab-Oprm Efflux Pump Expression and Enhances Antibiotic Resistance in Both Laboratory and Clinical Nalb-Type Isolates of Pseudomonas Aeruginosa

Phenazine-1 carboxylic acid of Pseudomonas aeruginosa induces the expression of Staphylococcus aureus Tet38 MDR efflux pump and mediates resistance to phenazines and antibiotics

Substrate dependence of transport coupling and phenotype of a small multidrug resistance transporter in Pseudomonas aeruginosa

Non-interchangeable functions of efflux transporters of Pseudomonas aeruginosa in survival under infection-associated stress

Quantifying bacterial efflux within subcellular domains of Pseudomonas aeruginosa

Cell division factor ZapE regulates Pseudomonas aeruginosa biofilm formation by impacting the pqs quorum sensing system

Characterization and Implications of IncP-2A Plasmid pMAS152 Harboring Multidrug Resistance Genes in Extensively Drug-Resistant Pseudomonas aeruginosa

Study on the multi-drug efflux pump of carbapenem-resistant Pseudomonas aeruginosa